title: The myelodysplastic syndrome as a prototypical epigenetic disease.
abstract: The myelodysplastic syndrome (MDS) is a clonal disorder characterized by increased stem cell proliferation coupled with aberrant differentiation resulting in a high rate of apoptosis and eventual symptoms related to bone marrow failure. Cellular differentiation is an epigenetic process that requires specific and highly ordered DNA methylation and histone modification programs. Aberrant differentiation in MDS can often be traced to abnormal DNA methylation (both gains and losses of DNA methylation genome wide and at specific loci) as well as mutations in genes that regulate epigenetic programs (TET2 and DNMT3a, both involved in DNA methylation control; EZH2 and ASXL1, both involved in histone methylation control). The epigenetic nature of MDS may explain in part the serendipitous observation that it is the disease most responsive to DNA methylation inhibitors; other epigenetic-acting drugs are being explored in MDS as well. Progression in MDS is characterized by further acquisition of epigenetic defects as well as mutations in growth-controlling genes that seem to tip the proliferation/apoptosis balance and result in the development of acute myelogenous leukemia. Although MDS is clinically and physiologically heterogeneous, a case can be made that subsets of the disease can be largely explained by disordered stem cell epigenetics.
authors: Fels Institute, Temple University School of Medicine, Philadelphia, PA 19140, USA.jpissa@temple.edu
authors: Jean-Pierre J
authors: JP
authors: Issa
mesh_terms: D019175:DNA Methylation / Q000502:physiology; D044127:Epigenesis, Genetic / Q000235:genetics / Q000502:physiology*; D006801:Humans; D009190:Myelodysplastic Syndromes / Q000235:genetics*
references: Hematol Oncol Clin North Am. 1992 Jun;6(3):543-56
references: 1613005
references: Nat Genet. 2011 Dec 04;44(1):23-31
references: 22138693
references: PLoS One. 2007 May 02;2(5):e399
references: 17476321
references: Blood. 2009 Oct 15;114(16):3448-58
references: 19652201
references: Leukemia. 2011 Jun;25(6):909-20
references: 21445077
references: Lancet Oncol. 2009 Mar;10(3):223-32
references: 19230772
references: Nat Med. 2010 Jan;16(1):59-66
references: 19966810
references: Eur J Hum Genet. 2011 Mar;19(3):313-9
references: 21150891
references: J Clin Oncol. 2010 Feb 1;28(4):605-13
references: 20038729
references: Nat Rev Immunol. 2011 Jun 10;11(7):478-88
references: 21660052
references: Clin Cancer Res. 2013 Feb 15;19(4):938-48
references: 23287564
references: Nat Genet. 1994 Aug;7(4):536-40
references: 7951326
references: Ann Hematol. 2012 Nov;91(11):1713-20
references: 23010802
references: Science. 2001 Aug 10;293(5532):1074-80
references: 11498575
references: Nat Genet. 2011 Jul 27;43(8):724-6
references: 21792236
references: J Clin Oncol. 2005 Jun 10;23(17):3948-56
references: 15883410
references: Leukemia. 2012 May;26(5):1106-7
references: 22124213
references: Am J Med. 2012 Jul;125(7 Suppl):S6-13
references: 22735753
references: Semin Hematol. 2002 Oct;39(4 Suppl 3):6-11
references: 12447846
references: Leukemia. 2010 Aug;24(8):1528-32
references: 20520634
references: Nat Rev Cancer. 2012 Sep;12(9):599-612
references: 22898539
references: Transcription. 2012 May-Jun;3(3):106-9
references: 22771943
references: N Engl J Med. 2010 Dec 16;363(25):2424-33
references: 21067377
references: Nat Genet. 2010 Aug;42(8):665-7
references: 20601954
references: Exp Hematol. 2007 Mar;35(3):394-406
references: 17309820
references: Trends Biochem Sci. 2010 Jun;35(6):323-32
references: 20346678
references: Cancer Res. 2012 Mar 1;72(5):1170-81
references: 22219169
references: Cancer Lett. 2009 Aug 8;280(2):192-200
references: 19345475
references: Nat Struct Mol Biol. 2012 Oct;19(10):998-1004
references: 22961379
references: Nature. 2010 Dec 9;468(7325):839-43
references: 21057493
references: Cancer. 2007 Mar 15;109(6):1133-7
references: 17315156
references: Exp Hematol. 2007 Nov;35(11):1739-46
references: 17976524
references: Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):2989-94
references: 22323599
references: Cell. 2007 Feb 23;128(4):683-92
references: 17320506
references: Blood. 2009 Sep 24;114(13):2764-73
references: 19546476
references: PLoS One. 2011;6(8):e23372
references: 21858090
references: Hematol Oncol Clin North Am. 2010 Apr;24(2):443-57
references: 20359636
references: Cancer Cell. 2010 Dec 14;18(6):553-67
references: 21130701
references: Genome Res. 2010 Apr;20(4):434-9
references: 20219945
references: Nature. 2009 Nov 19;462(7271):315-22
references: 19829295
references: Genome Res. 2010 Mar;20(3):332-40
references: 20107151
references: Blood. 2007 Jan 1;109(1):52-7
references: 16882708
references: Blood. 2008 Feb 15;111(4):2382-4
references: 18055864
references: Nat Genet. 2011 Mar 13;43(4):309-15
references: 21399634
references: Biochem Biophys Res Commun. 1979 Apr 13;87(3):698-705
references: 454420
references: Cancer Cell. 2011 Jul 12;20(1):11-24
references: 21723200
references: Blood. 1997 Aug 15;90(4):1403-9
references: 9269757
references: Cancer Cell. 2012 Aug 14;22(2):180-93
references: 22897849
references: PLoS Biol. 2007 Aug;5(8):e201
references: 17676974
references: Science. 2011 Feb 25;331(6020):1036-40
references: 21163962
references: Cell. 2007 Feb 23;128(4):669-81
references: 17320505
references: Development. 2012 Jun;139(11):1895-902
references: 22569552
references: Epigenetics. 2012 Feb;7(2):201-7
references: 22395470
references: Adv Genet. 2012;80:1-36
references: 23084872
references: J Clin Oncol. 2011 May 20;29(15):1987-96
references: 21483003
references: Leukemia. 2011 Jul;25(7):1153-8
references: 21415852
references: Blood. 2006 Nov 15;108(10):3271-9
references: 16882711
references: Clin Cancer Res. 2009 Jun 15;15(12):3938-46
references: 19509174
references: Br J Haematol. 2012 Jul;158(2):165-173
references: 22594801
references: Blood. 1987 Aug;70(2):412-7
references: 3607279
references: Nat Genet. 2009 Jul;41(7):838-42
references: 19483684
references: Nat Genet. 2011 Jun 26;43(8):768-75
references: 21706001
references: Blood. 2010 Nov 4;116(18):3564-71
references: 20498303
references: Cancer Res. 2008 Nov 15;68(22):9358-66
references: 19010910
references: Cell. 2002 Nov 1;111(3):281-4
references: 12419239
references: PLoS Genet. 2007 Oct;3(10):2023-36
references: 17967063
references: Nat Rev Mol Cell Biol. 2012 Jan 23;13(2):115-26
references: 22266761
references: Genes Dev. 2002 Jan 1;16(1):6-21
references: 11782440
references: Nat Genet. 2012 Nov;44(11):1179-81
references: 23001125
references: Proc Natl Acad Sci U S A. 2007 Nov 20;104(47):18654-9
references: 18003927